{"nct_id":"NCT01866319","title":"Study to Evaluate the Safety and Efficacy of Two Different Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Participants With Advanced Melanoma (MK-3475-006/KEYNOTE-006)","status":"COMPLETED","status_verified_date":"2020-05","start_date":"2013-08-28","start_date_type":"ACTUAL","primary_completion_date":"2015-03-03","primary_completion_date_type":"ACTUAL","completion_date":"2019-06-03","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}